SCHEMBL3542704

SCHEMBL3542704

NC1CCC(C2CCC(CC(=O)O)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.47
ENPEP Q07075 1/20 0.47
SLC6A12 P48065 5/20 0.45
SLC6A11 P48066 5/20 0.45
SLC6A13 Q9NSD5 5/20 0.45
SLC6A1 P30531 2/20 0.45
GABRA5 P31644 2/20 0.45
GABRB2 P47870 2/20 0.45
GABRA1 P14867 1/20 0.45
GABRR1 P24046 1/20 0.45
GABRA4 P48169 1/20 0.45
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PLG P00747 1/20 0.34
PLAT P00750 1/20 0.34
LMNA P02545 1/20 0.34
HSD11B1 P28845 1/20 0.34
DGAT1 O75907 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3542706 1.00 ANPEP (0.47) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL200897 0.93 ANPEP (0.52) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL229034 0.93 ANPEP (0.52) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL200896 0.93 ANPEP (0.52) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL2993124 0.91 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL4276196 0.91 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Hydrochloric Acid SCHEMBL2993122 0.91 ANPEP (0.50) ANPEPENPEPSLC6A12SLC6A11SLC6A13
SCHEMBL19928149 0.90 SLC6A12 (0.42) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Sulfuric Acid SCHEMBL4208349 0.85 ANPEP (0.46) ANPEPENPEPSLC6A12SLC6A11SLC6A13
Sulfuric Acid SCHEMBL7803541 0.85 ANPEP (0.46) ANPEPENPEPSLC6A12SLC6A11SLC6A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317653-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS ASTRAZENECA AB (SE) 2010-12-16 US disclosed
US-7795283-B2 Oxadiazole derivative as DGAT inhibitors ASTRAZENECA AB (SE) 2010-09-14 US disclosed
US-20080096874-A1 Oxadiazole Derivative as Dgat Inhibitors ASTRAZENECA AB (SE) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317653-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS DGAT1, DGAT2, GPR119 ANPEP 1442/4885ENPEP 1963/4885SLC6A12 776/4885
US-20080096874-A1 Oxadiazole Derivative as Dgat Inhibitors DGAT1, DGAT2, GPR119 ANPEP 1353/4885ENPEP 1768/4885SLC6A12 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.